PT - JOURNAL ARTICLE AU - Chris Nadege Nganou-Gnindjio AU - Mazou Ngou Temgoua AU - Liliane Mfeukeu Kuate AU - Clovis Nkoke AU - Joel Noutakdie Tochie AU - Valerie Ndobo-Kue AU - Amalia Owona-Nsiaguam AU - Jerome Boombhi AU - Richie Kipenge AU - Urbain Huba AU - Malick Kane AU - Mohamed Taha el Jirari AU - Sylvie Ndongo-Amougou AU - Bâ Hamadou AU - Alain Menanga AU - Samuel Kingue TI - A multinational e-survey on the delivery of cardiology services in Africa during the COVID-19 pandemic: what should we expect after this pandemic? AID - 10.1101/2020.07.24.20160390 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.24.20160390 4099 - http://medrxiv.org/content/early/2020/07/24/2020.07.24.20160390.short 4100 - http://medrxiv.org/content/early/2020/07/24/2020.07.24.20160390.full AB - Objective To evaluate the impact of the COVID-19 pandemic on the delivery of cardiology services in Africa.Design Cross-sectional e-survey study.Setting African countriesParticipants CardiologistsPrimary and Secondary outcomes measures The primary outcome was the change in service delivery in African cardiology units during the on-going COVID-19 pandemic. The secondary outcomes were the satisfaction of cardiologists with regards to the workload and factors associated with this satisfaction.Results There was a significant reduction in working time and the number of patients consulted by week during this pandemic (p<0.001). In general, there was a decrease in the overall activities in cardiovascular care delivery. The majority of cardiology services (76.5%) and consulting programs (85%) were adjusted to the pandemic. Only half of the participants were satisfied with their workload. Reconfiguration of the consultation schedule was associated with a reduced satisfaction of participants (p=0.02).Conclusions COVID-19 is associated with an overall reduction in cardiology services rendered in Africa. Since the cardiovascular burdens continue to increase in this part of the World and the risk of cardiovascular complications linked to SARS COV2 remains unchanged cardiology, departments in Africa should anticipate a significant surge of cardiology services demanded by patients after the COVID-19 pandemic.Strengths and limitations of this studyThe study is one of the first African studies to report the impact of the COVID-19 pandemic on the delivery of cardiology services which are very important for Africans given the high prevalence of cardiovascular diseases in this continent.The multinational design of the study leading to the inclusion of 14 African countries makes the results generalizable to the entire African.The cross-sectional design of the study represents a major limitation as it remains impossible to either infer causality or untangle bi-directional relationships between the reduction of the delivery in cardiology services and the pandemic or participants’ satisfaction.Also, the e-survey was drawn in English and this might have restricted the participation by some non-English African respondents due to the language barrier. Hence, perhaps contributing to the relatively small sample size of the study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the National Committee for Research Ethics in Human Health, CameroonAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData could be access to https://docs.google.com/forms/d/1A3SBAqwyKvIOhv-rI7LArBVqvUNIDulBmBct9pkQWv0/edit.